nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—CYP3A4—Vandetanib—thyroid cancer	0.068	0.286	CbGbCtD
Rivastigmine—CYP2D6—Sorafenib—thyroid cancer	0.0645	0.272	CbGbCtD
Rivastigmine—CYP3A4—Sorafenib—thyroid cancer	0.041	0.173	CbGbCtD
Rivastigmine—CYP2D6—Doxorubicin—thyroid cancer	0.0391	0.165	CbGbCtD
Rivastigmine—CYP3A4—Doxorubicin—thyroid cancer	0.0249	0.105	CbGbCtD
Rivastigmine—Hypokalaemia—Epirubicin—thyroid cancer	0.000514	0.000674	CcSEcCtD
Rivastigmine—Diarrhoea—Sorafenib—thyroid cancer	0.000514	0.000674	CcSEcCtD
Rivastigmine—Breast disorder—Epirubicin—thyroid cancer	0.000511	0.000669	CcSEcCtD
Rivastigmine—Nasopharyngitis—Epirubicin—thyroid cancer	0.000505	0.000662	CcSEcCtD
Rivastigmine—Face oedema—Doxorubicin—thyroid cancer	0.000505	0.000662	CcSEcCtD
Rivastigmine—Gastritis—Epirubicin—thyroid cancer	0.0005	0.000656	CcSEcCtD
Rivastigmine—Muscular weakness—Epirubicin—thyroid cancer	0.000498	0.000653	CcSEcCtD
Rivastigmine—Cardiac arrest—Doxorubicin—thyroid cancer	0.000497	0.000652	CcSEcCtD
Rivastigmine—Dizziness—Sorafenib—thyroid cancer	0.000497	0.000652	CcSEcCtD
Rivastigmine—Mood swings—Doxorubicin—thyroid cancer	0.000495	0.000649	CcSEcCtD
Rivastigmine—Ataxia—Doxorubicin—thyroid cancer	0.000492	0.000645	CcSEcCtD
Rivastigmine—Dysphagia—Epirubicin—thyroid cancer	0.000488	0.00064	CcSEcCtD
Rivastigmine—Dehydration—Doxorubicin—thyroid cancer	0.000486	0.000637	CcSEcCtD
Rivastigmine—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000483	0.000633	CcSEcCtD
Rivastigmine—Dry skin—Doxorubicin—thyroid cancer	0.000479	0.000628	CcSEcCtD
Rivastigmine—Pancreatitis—Epirubicin—thyroid cancer	0.000479	0.000628	CcSEcCtD
Rivastigmine—Vomiting—Sorafenib—thyroid cancer	0.000478	0.000626	CcSEcCtD
Rivastigmine—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000477	0.000626	CcSEcCtD
Rivastigmine—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000477	0.000626	CcSEcCtD
Rivastigmine—Hypokalaemia—Doxorubicin—thyroid cancer	0.000476	0.000624	CcSEcCtD
Rivastigmine—Angina pectoris—Epirubicin—thyroid cancer	0.000476	0.000624	CcSEcCtD
Rivastigmine—Rash—Sorafenib—thyroid cancer	0.000474	0.000621	CcSEcCtD
Rivastigmine—Dermatitis—Sorafenib—thyroid cancer	0.000473	0.000621	CcSEcCtD
Rivastigmine—Breast disorder—Doxorubicin—thyroid cancer	0.000472	0.000619	CcSEcCtD
Rivastigmine—Headache—Sorafenib—thyroid cancer	0.000471	0.000617	CcSEcCtD
Rivastigmine—Bronchitis—Epirubicin—thyroid cancer	0.00047	0.000616	CcSEcCtD
Rivastigmine—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000467	0.000613	CcSEcCtD
Rivastigmine—Gastritis—Doxorubicin—thyroid cancer	0.000463	0.000607	CcSEcCtD
Rivastigmine—Muscular weakness—Doxorubicin—thyroid cancer	0.000461	0.000605	CcSEcCtD
Rivastigmine—Dysuria—Epirubicin—thyroid cancer	0.000457	0.000599	CcSEcCtD
Rivastigmine—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000454	0.000595	CcSEcCtD
Rivastigmine—Dysphagia—Doxorubicin—thyroid cancer	0.000452	0.000592	CcSEcCtD
Rivastigmine—Pollakiuria—Epirubicin—thyroid cancer	0.000451	0.000592	CcSEcCtD
Rivastigmine—Nausea—Sorafenib—thyroid cancer	0.000446	0.000585	CcSEcCtD
Rivastigmine—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000446	0.000584	CcSEcCtD
Rivastigmine—Weight increased—Epirubicin—thyroid cancer	0.000444	0.000583	CcSEcCtD
Rivastigmine—Pancreatitis—Doxorubicin—thyroid cancer	0.000443	0.000581	CcSEcCtD
Rivastigmine—Weight decreased—Epirubicin—thyroid cancer	0.000442	0.000579	CcSEcCtD
Rivastigmine—Hyperglycaemia—Epirubicin—thyroid cancer	0.00044	0.000578	CcSEcCtD
Rivastigmine—Angina pectoris—Doxorubicin—thyroid cancer	0.00044	0.000577	CcSEcCtD
Rivastigmine—Pneumonia—Epirubicin—thyroid cancer	0.000438	0.000574	CcSEcCtD
Rivastigmine—Infestation—Epirubicin—thyroid cancer	0.000435	0.000571	CcSEcCtD
Rivastigmine—Infestation NOS—Epirubicin—thyroid cancer	0.000435	0.000571	CcSEcCtD
Rivastigmine—Drowsiness—Epirubicin—thyroid cancer	0.000435	0.000571	CcSEcCtD
Rivastigmine—Bronchitis—Doxorubicin—thyroid cancer	0.000435	0.00057	CcSEcCtD
Rivastigmine—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000432	0.000566	CcSEcCtD
Rivastigmine—Renal failure—Epirubicin—thyroid cancer	0.000428	0.000561	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000427	0.00056	CcSEcCtD
Rivastigmine—Urinary tract infection—Epirubicin—thyroid cancer	0.000423	0.000555	CcSEcCtD
Rivastigmine—Conjunctivitis—Epirubicin—thyroid cancer	0.000423	0.000555	CcSEcCtD
Rivastigmine—Dysuria—Doxorubicin—thyroid cancer	0.000422	0.000554	CcSEcCtD
Rivastigmine—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00042	0.000551	CcSEcCtD
Rivastigmine—Sweating—Epirubicin—thyroid cancer	0.000417	0.000547	CcSEcCtD
Rivastigmine—Pollakiuria—Doxorubicin—thyroid cancer	0.000417	0.000547	CcSEcCtD
Rivastigmine—Haematuria—Epirubicin—thyroid cancer	0.000415	0.000544	CcSEcCtD
Rivastigmine—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000412	0.000541	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000412	0.00054	CcSEcCtD
Rivastigmine—Weight increased—Doxorubicin—thyroid cancer	0.000411	0.000539	CcSEcCtD
Rivastigmine—Epistaxis—Epirubicin—thyroid cancer	0.000411	0.000538	CcSEcCtD
Rivastigmine—Weight decreased—Doxorubicin—thyroid cancer	0.000409	0.000536	CcSEcCtD
Rivastigmine—Sinusitis—Epirubicin—thyroid cancer	0.000408	0.000536	CcSEcCtD
Rivastigmine—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000408	0.000534	CcSEcCtD
Rivastigmine—Pneumonia—Doxorubicin—thyroid cancer	0.000405	0.000531	CcSEcCtD
Rivastigmine—Infestation—Doxorubicin—thyroid cancer	0.000403	0.000528	CcSEcCtD
Rivastigmine—Infestation NOS—Doxorubicin—thyroid cancer	0.000403	0.000528	CcSEcCtD
Rivastigmine—Drowsiness—Doxorubicin—thyroid cancer	0.000403	0.000528	CcSEcCtD
Rivastigmine—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000399	0.000524	CcSEcCtD
Rivastigmine—Bradycardia—Epirubicin—thyroid cancer	0.000398	0.000522	CcSEcCtD
Rivastigmine—Renal failure—Doxorubicin—thyroid cancer	0.000396	0.000519	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000395	0.000518	CcSEcCtD
Rivastigmine—Haemoglobin—Epirubicin—thyroid cancer	0.000393	0.000515	CcSEcCtD
Rivastigmine—Rhinitis—Epirubicin—thyroid cancer	0.000392	0.000514	CcSEcCtD
Rivastigmine—Conjunctivitis—Doxorubicin—thyroid cancer	0.000392	0.000513	CcSEcCtD
Rivastigmine—Urinary tract infection—Doxorubicin—thyroid cancer	0.000392	0.000513	CcSEcCtD
Rivastigmine—Haemorrhage—Epirubicin—thyroid cancer	0.000391	0.000513	CcSEcCtD
Rivastigmine—Hepatitis—Epirubicin—thyroid cancer	0.000391	0.000513	CcSEcCtD
Rivastigmine—Hypoaesthesia—Epirubicin—thyroid cancer	0.000389	0.00051	CcSEcCtD
Rivastigmine—Pharyngitis—Epirubicin—thyroid cancer	0.000388	0.000509	CcSEcCtD
Rivastigmine—Sweating—Doxorubicin—thyroid cancer	0.000386	0.000506	CcSEcCtD
Rivastigmine—Urinary tract disorder—Epirubicin—thyroid cancer	0.000386	0.000506	CcSEcCtD
Rivastigmine—Oedema peripheral—Epirubicin—thyroid cancer	0.000385	0.000505	CcSEcCtD
Rivastigmine—Haematuria—Doxorubicin—thyroid cancer	0.000384	0.000504	CcSEcCtD
Rivastigmine—Connective tissue disorder—Epirubicin—thyroid cancer	0.000384	0.000504	CcSEcCtD
Rivastigmine—Urethral disorder—Epirubicin—thyroid cancer	0.000383	0.000502	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000381	0.0005	CcSEcCtD
Rivastigmine—Epistaxis—Doxorubicin—thyroid cancer	0.00038	0.000498	CcSEcCtD
Rivastigmine—Sinusitis—Doxorubicin—thyroid cancer	0.000378	0.000496	CcSEcCtD
Rivastigmine—Visual impairment—Epirubicin—thyroid cancer	0.000377	0.000494	CcSEcCtD
Rivastigmine—Erythema multiforme—Epirubicin—thyroid cancer	0.00037	0.000485	CcSEcCtD
Rivastigmine—Bradycardia—Doxorubicin—thyroid cancer	0.000368	0.000483	CcSEcCtD
Rivastigmine—Eye disorder—Epirubicin—thyroid cancer	0.000365	0.000479	CcSEcCtD
Rivastigmine—Tinnitus—Epirubicin—thyroid cancer	0.000364	0.000478	CcSEcCtD
Rivastigmine—Haemoglobin—Doxorubicin—thyroid cancer	0.000363	0.000477	CcSEcCtD
Rivastigmine—Flushing—Epirubicin—thyroid cancer	0.000363	0.000476	CcSEcCtD
Rivastigmine—Cardiac disorder—Epirubicin—thyroid cancer	0.000363	0.000476	CcSEcCtD
Rivastigmine—Rhinitis—Doxorubicin—thyroid cancer	0.000363	0.000475	CcSEcCtD
Rivastigmine—Haemorrhage—Doxorubicin—thyroid cancer	0.000362	0.000474	CcSEcCtD
Rivastigmine—Hepatitis—Doxorubicin—thyroid cancer	0.000362	0.000474	CcSEcCtD
Rivastigmine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00036	0.000472	CcSEcCtD
Rivastigmine—Pharyngitis—Doxorubicin—thyroid cancer	0.000359	0.000471	CcSEcCtD
Rivastigmine—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000357	0.000468	CcSEcCtD
Rivastigmine—Oedema peripheral—Doxorubicin—thyroid cancer	0.000356	0.000467	CcSEcCtD
Rivastigmine—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000355	0.000466	CcSEcCtD
Rivastigmine—Angiopathy—Epirubicin—thyroid cancer	0.000355	0.000465	CcSEcCtD
Rivastigmine—Urethral disorder—Doxorubicin—thyroid cancer	0.000355	0.000465	CcSEcCtD
Rivastigmine—Mediastinal disorder—Epirubicin—thyroid cancer	0.000352	0.000462	CcSEcCtD
Rivastigmine—Chills—Epirubicin—thyroid cancer	0.000351	0.00046	CcSEcCtD
Rivastigmine—Arrhythmia—Epirubicin—thyroid cancer	0.000349	0.000458	CcSEcCtD
Rivastigmine—Visual impairment—Doxorubicin—thyroid cancer	0.000349	0.000457	CcSEcCtD
Rivastigmine—Alopecia—Epirubicin—thyroid cancer	0.000345	0.000453	CcSEcCtD
Rivastigmine—Mental disorder—Epirubicin—thyroid cancer	0.000342	0.000449	CcSEcCtD
Rivastigmine—Erythema multiforme—Doxorubicin—thyroid cancer	0.000342	0.000448	CcSEcCtD
Rivastigmine—Malnutrition—Epirubicin—thyroid cancer	0.00034	0.000446	CcSEcCtD
Rivastigmine—Erythema—Epirubicin—thyroid cancer	0.00034	0.000446	CcSEcCtD
Rivastigmine—Eye disorder—Doxorubicin—thyroid cancer	0.000338	0.000443	CcSEcCtD
Rivastigmine—Tinnitus—Doxorubicin—thyroid cancer	0.000337	0.000442	CcSEcCtD
Rivastigmine—Cardiac disorder—Doxorubicin—thyroid cancer	0.000336	0.00044	CcSEcCtD
Rivastigmine—Flushing—Doxorubicin—thyroid cancer	0.000336	0.00044	CcSEcCtD
Rivastigmine—Flatulence—Epirubicin—thyroid cancer	0.000335	0.00044	CcSEcCtD
Rivastigmine—Tension—Epirubicin—thyroid cancer	0.000334	0.000438	CcSEcCtD
Rivastigmine—Dysgeusia—Epirubicin—thyroid cancer	0.000333	0.000437	CcSEcCtD
Rivastigmine—Nervousness—Epirubicin—thyroid cancer	0.00033	0.000433	CcSEcCtD
Rivastigmine—Back pain—Epirubicin—thyroid cancer	0.000329	0.000432	CcSEcCtD
Rivastigmine—Angiopathy—Doxorubicin—thyroid cancer	0.000328	0.00043	CcSEcCtD
Rivastigmine—Muscle spasms—Epirubicin—thyroid cancer	0.000327	0.000429	CcSEcCtD
Rivastigmine—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000326	0.000427	CcSEcCtD
Rivastigmine—Chills—Doxorubicin—thyroid cancer	0.000324	0.000426	CcSEcCtD
Rivastigmine—Arrhythmia—Doxorubicin—thyroid cancer	0.000323	0.000424	CcSEcCtD
Rivastigmine—Vision blurred—Epirubicin—thyroid cancer	0.000321	0.00042	CcSEcCtD
Rivastigmine—Alopecia—Doxorubicin—thyroid cancer	0.00032	0.000419	CcSEcCtD
Rivastigmine—Mental disorder—Doxorubicin—thyroid cancer	0.000317	0.000415	CcSEcCtD
Rivastigmine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000316	0.000414	CcSEcCtD
Rivastigmine—Malnutrition—Doxorubicin—thyroid cancer	0.000315	0.000413	CcSEcCtD
Rivastigmine—Erythema—Doxorubicin—thyroid cancer	0.000315	0.000413	CcSEcCtD
Rivastigmine—Anaemia—Epirubicin—thyroid cancer	0.000314	0.000412	CcSEcCtD
Rivastigmine—Agitation—Epirubicin—thyroid cancer	0.000313	0.00041	CcSEcCtD
Rivastigmine—Flatulence—Doxorubicin—thyroid cancer	0.00031	0.000407	CcSEcCtD
Rivastigmine—Tension—Doxorubicin—thyroid cancer	0.000309	0.000405	CcSEcCtD
Rivastigmine—Dysgeusia—Doxorubicin—thyroid cancer	0.000308	0.000404	CcSEcCtD
Rivastigmine—Malaise—Epirubicin—thyroid cancer	0.000307	0.000402	CcSEcCtD
Rivastigmine—Nervousness—Doxorubicin—thyroid cancer	0.000306	0.000401	CcSEcCtD
Rivastigmine—Vertigo—Epirubicin—thyroid cancer	0.000306	0.000401	CcSEcCtD
Rivastigmine—Syncope—Epirubicin—thyroid cancer	0.000305	0.0004	CcSEcCtD
Rivastigmine—Back pain—Doxorubicin—thyroid cancer	0.000305	0.000399	CcSEcCtD
Rivastigmine—Muscle spasms—Doxorubicin—thyroid cancer	0.000303	0.000397	CcSEcCtD
Rivastigmine—Palpitations—Epirubicin—thyroid cancer	0.000301	0.000394	CcSEcCtD
Rivastigmine—Loss of consciousness—Epirubicin—thyroid cancer	0.000299	0.000392	CcSEcCtD
Rivastigmine—Cough—Epirubicin—thyroid cancer	0.000297	0.000389	CcSEcCtD
Rivastigmine—Vision blurred—Doxorubicin—thyroid cancer	0.000297	0.000389	CcSEcCtD
Rivastigmine—Convulsion—Epirubicin—thyroid cancer	0.000295	0.000387	CcSEcCtD
Rivastigmine—Hypertension—Epirubicin—thyroid cancer	0.000294	0.000385	CcSEcCtD
Rivastigmine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000292	0.000383	CcSEcCtD
Rivastigmine—Anaemia—Doxorubicin—thyroid cancer	0.000291	0.000382	CcSEcCtD
Rivastigmine—Chest pain—Epirubicin—thyroid cancer	0.00029	0.00038	CcSEcCtD
Rivastigmine—Myalgia—Epirubicin—thyroid cancer	0.00029	0.00038	CcSEcCtD
Rivastigmine—Arthralgia—Epirubicin—thyroid cancer	0.00029	0.00038	CcSEcCtD
Rivastigmine—Agitation—Doxorubicin—thyroid cancer	0.000289	0.000379	CcSEcCtD
Rivastigmine—Anxiety—Epirubicin—thyroid cancer	0.000289	0.000379	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000288	0.000377	CcSEcCtD
Rivastigmine—Discomfort—Epirubicin—thyroid cancer	0.000286	0.000375	CcSEcCtD
Rivastigmine—Malaise—Doxorubicin—thyroid cancer	0.000284	0.000372	CcSEcCtD
Rivastigmine—Dry mouth—Epirubicin—thyroid cancer	0.000283	0.000371	CcSEcCtD
Rivastigmine—Vertigo—Doxorubicin—thyroid cancer	0.000283	0.000371	CcSEcCtD
Rivastigmine—Syncope—Doxorubicin—thyroid cancer	0.000282	0.00037	CcSEcCtD
Rivastigmine—Confusional state—Epirubicin—thyroid cancer	0.00028	0.000367	CcSEcCtD
Rivastigmine—Palpitations—Doxorubicin—thyroid cancer	0.000278	0.000365	CcSEcCtD
Rivastigmine—Oedema—Epirubicin—thyroid cancer	0.000278	0.000364	CcSEcCtD
Rivastigmine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000277	0.000363	CcSEcCtD
Rivastigmine—Infection—Epirubicin—thyroid cancer	0.000276	0.000362	CcSEcCtD
Rivastigmine—Cough—Doxorubicin—thyroid cancer	0.000275	0.00036	CcSEcCtD
Rivastigmine—Shock—Epirubicin—thyroid cancer	0.000273	0.000358	CcSEcCtD
Rivastigmine—Convulsion—Doxorubicin—thyroid cancer	0.000273	0.000358	CcSEcCtD
Rivastigmine—Nervous system disorder—Epirubicin—thyroid cancer	0.000272	0.000357	CcSEcCtD
Rivastigmine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000272	0.000357	CcSEcCtD
Rivastigmine—Hypertension—Doxorubicin—thyroid cancer	0.000272	0.000356	CcSEcCtD
Rivastigmine—Tachycardia—Epirubicin—thyroid cancer	0.000271	0.000355	CcSEcCtD
Rivastigmine—Skin disorder—Epirubicin—thyroid cancer	0.00027	0.000354	CcSEcCtD
Rivastigmine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000268	0.000352	CcSEcCtD
Rivastigmine—Myalgia—Doxorubicin—thyroid cancer	0.000268	0.000351	CcSEcCtD
Rivastigmine—Chest pain—Doxorubicin—thyroid cancer	0.000268	0.000351	CcSEcCtD
Rivastigmine—Arthralgia—Doxorubicin—thyroid cancer	0.000268	0.000351	CcSEcCtD
Rivastigmine—Anxiety—Doxorubicin—thyroid cancer	0.000267	0.00035	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000266	0.000349	CcSEcCtD
Rivastigmine—Discomfort—Doxorubicin—thyroid cancer	0.000265	0.000347	CcSEcCtD
Rivastigmine—Anorexia—Epirubicin—thyroid cancer	0.000265	0.000347	CcSEcCtD
Rivastigmine—Dry mouth—Doxorubicin—thyroid cancer	0.000262	0.000344	CcSEcCtD
Rivastigmine—Hypotension—Epirubicin—thyroid cancer	0.000259	0.00034	CcSEcCtD
Rivastigmine—Confusional state—Doxorubicin—thyroid cancer	0.000259	0.00034	CcSEcCtD
Rivastigmine—Oedema—Doxorubicin—thyroid cancer	0.000257	0.000337	CcSEcCtD
Rivastigmine—Infection—Doxorubicin—thyroid cancer	0.000255	0.000335	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000253	0.000332	CcSEcCtD
Rivastigmine—Shock—Doxorubicin—thyroid cancer	0.000253	0.000331	CcSEcCtD
Rivastigmine—Nervous system disorder—Doxorubicin—thyroid cancer	0.000252	0.00033	CcSEcCtD
Rivastigmine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000252	0.00033	CcSEcCtD
Rivastigmine—Insomnia—Epirubicin—thyroid cancer	0.000251	0.000329	CcSEcCtD
Rivastigmine—Tachycardia—Doxorubicin—thyroid cancer	0.000251	0.000329	CcSEcCtD
Rivastigmine—Skin disorder—Doxorubicin—thyroid cancer	0.00025	0.000327	CcSEcCtD
Rivastigmine—Paraesthesia—Epirubicin—thyroid cancer	0.000249	0.000327	CcSEcCtD
Rivastigmine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000248	0.000326	CcSEcCtD
Rivastigmine—Dyspnoea—Epirubicin—thyroid cancer	0.000248	0.000325	CcSEcCtD
Rivastigmine—Somnolence—Epirubicin—thyroid cancer	0.000247	0.000324	CcSEcCtD
Rivastigmine—Anorexia—Doxorubicin—thyroid cancer	0.000245	0.000321	CcSEcCtD
Rivastigmine—Dyspepsia—Epirubicin—thyroid cancer	0.000244	0.000321	CcSEcCtD
Rivastigmine—Decreased appetite—Epirubicin—thyroid cancer	0.000241	0.000317	CcSEcCtD
Rivastigmine—Hypotension—Doxorubicin—thyroid cancer	0.00024	0.000315	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00024	0.000314	CcSEcCtD
Rivastigmine—Fatigue—Epirubicin—thyroid cancer	0.000239	0.000314	CcSEcCtD
Rivastigmine—Pain—Epirubicin—thyroid cancer	0.000237	0.000311	CcSEcCtD
Rivastigmine—Constipation—Epirubicin—thyroid cancer	0.000237	0.000311	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000234	0.000307	CcSEcCtD
Rivastigmine—Insomnia—Doxorubicin—thyroid cancer	0.000232	0.000305	CcSEcCtD
Rivastigmine—Paraesthesia—Doxorubicin—thyroid cancer	0.000231	0.000303	CcSEcCtD
Rivastigmine—Dyspnoea—Doxorubicin—thyroid cancer	0.000229	0.0003	CcSEcCtD
Rivastigmine—Feeling abnormal—Epirubicin—thyroid cancer	0.000229	0.0003	CcSEcCtD
Rivastigmine—Somnolence—Doxorubicin—thyroid cancer	0.000228	0.0003	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000227	0.000298	CcSEcCtD
Rivastigmine—Dyspepsia—Doxorubicin—thyroid cancer	0.000226	0.000297	CcSEcCtD
Rivastigmine—Decreased appetite—Doxorubicin—thyroid cancer	0.000223	0.000293	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000222	0.000291	CcSEcCtD
Rivastigmine—Fatigue—Doxorubicin—thyroid cancer	0.000222	0.00029	CcSEcCtD
Rivastigmine—Urticaria—Epirubicin—thyroid cancer	0.000221	0.000289	CcSEcCtD
Rivastigmine—Pain—Doxorubicin—thyroid cancer	0.00022	0.000288	CcSEcCtD
Rivastigmine—Constipation—Doxorubicin—thyroid cancer	0.00022	0.000288	CcSEcCtD
Rivastigmine—Body temperature increased—Epirubicin—thyroid cancer	0.00022	0.000288	CcSEcCtD
Rivastigmine—Abdominal pain—Epirubicin—thyroid cancer	0.00022	0.000288	CcSEcCtD
Rivastigmine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000212	0.000278	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00021	0.000276	CcSEcCtD
Rivastigmine—Hypersensitivity—Epirubicin—thyroid cancer	0.000205	0.000268	CcSEcCtD
Rivastigmine—Urticaria—Doxorubicin—thyroid cancer	0.000204	0.000268	CcSEcCtD
Rivastigmine—Abdominal pain—Doxorubicin—thyroid cancer	0.000203	0.000266	CcSEcCtD
Rivastigmine—Body temperature increased—Doxorubicin—thyroid cancer	0.000203	0.000266	CcSEcCtD
Rivastigmine—Asthenia—Epirubicin—thyroid cancer	0.000199	0.000261	CcSEcCtD
Rivastigmine—Pruritus—Epirubicin—thyroid cancer	0.000196	0.000258	CcSEcCtD
Rivastigmine—Diarrhoea—Epirubicin—thyroid cancer	0.00019	0.000249	CcSEcCtD
Rivastigmine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000189	0.000248	CcSEcCtD
Rivastigmine—Asthenia—Doxorubicin—thyroid cancer	0.000184	0.000242	CcSEcCtD
Rivastigmine—Dizziness—Epirubicin—thyroid cancer	0.000184	0.000241	CcSEcCtD
Rivastigmine—Pruritus—Doxorubicin—thyroid cancer	0.000182	0.000238	CcSEcCtD
Rivastigmine—Vomiting—Epirubicin—thyroid cancer	0.000177	0.000232	CcSEcCtD
Rivastigmine—Diarrhoea—Doxorubicin—thyroid cancer	0.000176	0.000231	CcSEcCtD
Rivastigmine—Rash—Epirubicin—thyroid cancer	0.000175	0.00023	CcSEcCtD
Rivastigmine—Dermatitis—Epirubicin—thyroid cancer	0.000175	0.000229	CcSEcCtD
Rivastigmine—Headache—Epirubicin—thyroid cancer	0.000174	0.000228	CcSEcCtD
Rivastigmine—Dizziness—Doxorubicin—thyroid cancer	0.00017	0.000223	CcSEcCtD
Rivastigmine—Nausea—Epirubicin—thyroid cancer	0.000165	0.000216	CcSEcCtD
Rivastigmine—Vomiting—Doxorubicin—thyroid cancer	0.000163	0.000214	CcSEcCtD
Rivastigmine—Rash—Doxorubicin—thyroid cancer	0.000162	0.000212	CcSEcCtD
Rivastigmine—Dermatitis—Doxorubicin—thyroid cancer	0.000162	0.000212	CcSEcCtD
Rivastigmine—Headache—Doxorubicin—thyroid cancer	0.000161	0.000211	CcSEcCtD
Rivastigmine—Nausea—Doxorubicin—thyroid cancer	0.000153	0.0002	CcSEcCtD
